Assessing how well a modeling protocol captures a structure-activity landscape

被引:61
作者
Guha, Rajarshi [2 ]
Van Drie, John H. [1 ]
机构
[1] Van Drie Res LLC, Andover, MA 01810 USA
[2] Indiana Univ, Sch Informat, Bloomington, IN 47406 USA
关键词
D O I
10.1021/ci8001414
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We introduce the notion of structure-activity landscape index (SALI) curves as a way to assess a model and a modeling protocol, applied to structure-activity relationships. We start from our earlier work [J. Chem. Inf. Model., 2008, 48, 646-658], where we show how to study a structure-activity relationship pairwise, based on the notion of "activity cliffs"pairs of molecules that are structurally similar but have large differences in activity. There, we also introduced the SALI parameter, which allows one to identify cliffs easily, and which allows one to represent a structure-activity relationship as a graph. This graph orders every pair of molecules by their activity. Here, we introduce the new idea of a SALI curve, which tallies how many of these orderings a model is able to predict. Empirically, testing these SALI curves against a variety of models, ranging over two-dimensional quantitative structure-activity relationship (2D-QSAR), three-dimensional quantitative structure-activity relationship (3D-QSAR), and structure-based design models, the utility of a model seems to correspond to characteristics of these curves. In particular, the integral of these curves, denoted as SCI and being a number ranging from-1.0 to 1.0, approaches a value of 1.0 for two literature models, which are both known to be prospectively useful.
引用
收藏
页码:1716 / 1728
页数:13
相关论文
共 36 条
[1]   Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies [J].
Avery, MA ;
Alvim-Gaston, M ;
Rodrigues, CR ;
Barreiro, EJ ;
Cohen, FE ;
Sabnis, YA ;
Woolfrey, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :292-303
[2]   Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers [J].
Cavalli, A ;
Poluzzi, E ;
De Ponti, F ;
Recanatini, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3844-3853
[3]  
CHARIFSON PS, 1997, PRACTICAL APPL COMPU, P1
[4]   Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose [J].
Contrera, JF ;
Matthews, EJ ;
Kruhlak, NL ;
Benz, RD .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2004, 40 (03) :185-206
[5]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[6]   Beware of q2! [J].
Golbraikh, A ;
Tropsha, A .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (04) :269-276
[7]   Principles of QSAR models validation: internal and external [J].
Gramatica, Paola .
QSAR & COMBINATORIAL SCIENCE, 2007, 26 (05) :694-701
[8]   Determining the validity of a QSAR model - A classification approach [J].
Guha, R ;
Jurs, PC .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (01) :65-73
[9]   Development of QSAR models to predict and interpret the biological activity of artemisinin analogues [J].
Guha, R ;
Jurs, PC .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (04) :1440-1449
[10]   Development of linear, ensemble, and nonlinear models for the prediction and interpretation of the biological activity of a set of PDGFR inhibitors [J].
Guha, R ;
Jurs, PC .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (06) :2179-2189